Treatment of Parkinson's disease. Advances in the pharmacological therapy.
Ghika
J
J
Service de Neurologie, CHUV, Lausanne, Switzerland.
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D004298:Dopamine / Q000097:blood / Q000378:metabolism*; D015259:Dopamine Agents / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D015259:Dopamine Agents; D004791:Enzyme Inhibitors; D008996:Monoamine Oxidase Inhibitors; D018696:Neuroprotective Agents; D007980:Levodopa; D004298:Dopamine